Skip to content
naulon
Not checkedNot checked for notices yet.

Multiexperiment evaluation of increasing phytase activity from Optiphos® and Optiphos Plus® on 21-day broiler performance and tibia mineralization

V.E. Ayres, M.E. Jackson, S. A Cantley and 10 more

Journal of Applied Poultry Research · 2021

doi:10.1016/j.japr.2021.100210 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

SUMMARY: Phytase is used in nearly all broiler diets at varying levels and new commercial sources have been developed in recent years. A series of 5 experiments at 4 different universities were conducted to investigate broiler performance metrics and tibia mineralization from 2 mixer-added, Escherichia coli-derived, 6-phytases, Optiphos, a coated phytase, and Optiphos Plus, a recently developed phytase product selected to be intrinsically heat stable, independent of a coating. Treatments for each experiment included a negative control (NC) and the NC + varying levels of Optiphos and Optiphos Plus up to 1,500 FTU/kg. Experimental diets were fed to male broiler chicks for 21 d. On d 21, broilers were euthanized and tibiae were excised to determine tibia mineralization. Experiments 1–4 utilized pelleted diets while Experiment 5 utilized a mash diet. For each experiment, treatments were arranged by a formulated phytase level and source factorial, using a randomized complete block design. In addition, slope-ratio models were created using data from all experiments to evaluate responses to analyzed phytase levels. Positive live performance and tibia mineralization responses to phytase activity were observed (P < 0.05) in all 5 experiments. Performance and bone mineral metrics continued to improve up to approximately 1,500 FTU/kg in a curvilinear fashion, demonstrating a value of super-dosing, the degree employed being dependent on the product used and the cost-benefit economics of implementation. When comparing nonlinear response slopes across all analyzed phytase levels and experiments, the data showed that efficacy of Optiphos Plus was approximately 20% higher than that of Optiphos at similar analyzed levels (P < 0.05).

Abstract licence: CC BY-NC-ND

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.